The effectiveness of radiofrequency ablation and repeated cardioversion in combination with antiarrhythmic drug therapy in maintaining stable sinus rhythm in patients with atrial fibrillation and heart failure

Aim To compare the efficacy of radiofrequency ablation (RFA) and antiarrhythmic therapy (AAT) in patients with atrial fibrillation (AF) and chronic heart failure (CHF) during 12-month observation.
Materials and methods This prospective, nonrandomized comparative observational study included 130 patients with AF (men, 65 %; mean age, 62.8±11.8 years) and CHF with left ventricular ejection fraction (LV EF) <50 %. Paroxysmal AF was observed in 60 (46 %) patients and persistent AF was observed in 70 (54 %) patients. According to results of transthoracic echocardiography (EchoCG) 107 (82 %) patients had intermediate LV EF (40–49 %) and 23 (18 %) patients had reduced LV EF (<40 %). RFA of AF was performed for 65 patients whereas 65 patients received an optimal AAT. The 24-h electrocardiogram monitoring, EchoCG, and assessment of the quality of life (QoL) with the SF-36 questionnaire were performed for all patients on admission and at 12 months of observation. Stability of sinus rhythm, EchoCG, QoL, and exercise tolerance were evaluated at 12 months of observation.
Results 49 (75%) of patients in the RFA group and 26 (40%) of patients in the AAT group had stable sinus rhythm (SR) at 12 months. Repeated RFA for relapse of AF was performed for 6 (12 %) of 49 patients; repeated cardioversion was performed for 16 (61.5 %) of 26 patients. In the AAT group, there were more interventions for maintaining SR than in the RFA group (p<0.001). In patients with SR of the RFA group at 12 months of observation, LV EF was increased (р<0.001), left ventricular dimension (р<0.001) and volume (р<0.001) were decreased, and mental (р<0.001) and physical (p<0.001) components of health were improved according to the SF-36 questionnaire. In patients with SR of the AAT group, only improvement of mental (р<0.001) and physical (р<0.001) components of health was observed according to the SF-36 questionnaire.
Conclusion RFA provided a considerable decrease in the frequency of AF relapse and improvement of LV EF in patients with CHF. The effectiveness of RFA did not depend on the type of arrhythmia. For 12 months of observation, the number of hospitalizations for decompensated CHF and interventions to maintain SR decreased in the RFA group compared to the AAT group.

1. Sulimov V.A., Golitsin S.P., Panchenko E.P., Popov S.V., Revishvili A.Sh., Shubik Yu.V. et al. Diagnosis and treatment of atrial fibrillation. Recommendations of RSC, RSSA and ACVS. Russian Journal of Cardiology. 2013;18(4 S3):1–100.

2. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS et al. Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study. Circulation. 2004;110(9):1042–6. DOI: 10.1161/01.CIR.0000140263.20897.42

3. Mareev V.Yu., Fomin I.V., Ageev F.T., Begrambekova Yu.L., Vasyuk Yu.A., Garganeeva A.A. et al. Russian Heart Failure Society, Russian Society of Cardiology. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(6S):8–164. DOI: 10.18087/cardio.2475

4. Cowie MR, Wood DA, Coats AJ, Thompson SG, Suresh V, PooleWilson PA et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart (British Cardiac Society). 2000;83(5):505–10. PMID: 10768897

5. MacIntyre K, Capewell S, Stewart S, Chalmers JW, Boyd J, Finlayson A et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000;102(10):1126–31. DOI: 10.1161/01.cir.102.10.1126

6. Mosterd A, Cost B, Hoes AW, de Bruijne MC, Deckers JW, Hofman A et al. The prognosis of heart failure in the general population: The Rotterdam Study. European Heart Journal. 2001;22(15):1318–27. DOI: 10.1053/euhj.2000.2533

7. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271(11):840–4. DOI: 10.1001/jama.1994.03510350050036

8. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology. 2003;91(6A):2D-8D. DOI: 10.1016/S0002-9149(02)03373-8

9. Corell P, Gustafsson F, Schou M, Markenvard J, Nielsen T, Hildebrandt P. Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction. European Journal of Heart Failure. 2007;9(3):258–65. DOI: 10.1016/j.ejheart.2006.08.004

10. Shotan A, Garty M, Blondhein DS, Meisel SR, Lewis BS, Shochat M et al. Atrial fibrillation and long-term prognosis in patients hospitalized for heart failure: results from heart failure survey in Israel (HFSIS). European Heart Journal. 2010;31(3):309–17. DOI: 10.1093/eurheartj/ehp422

11. Kurita T, Motoki K, Yasuoka R, Hirota T, Akaiwa Y, Kotake Y et al. Rhythm Control Should Be Better for the Management of Patients With Atrial Fibrillation and Heart Failure. Circulation Journal. 2011;75(4):979–85. DOI: 10.1253/circj.CJ-11-0075

12. Tayebjee MH, Hunter RJ, Baker V, Creta A, Duncan E, Sporton S et al. Pulmonary vein isolation with radiofrequency ablation followed by cryotherapy: a novel strategy to improve clinical outcomes following catheter ablation of paroxysmal atrial fibrillation. Europace. 2011;13(9):1250–5. DOI: 10.1093/europace/eur140

13. Haïssaguerre M, Wright M, Hocini M, Jaïs P. The Substrate Maintaining Persistent Atrial Fibrillation. Circulation: Arrhythmia and Electrophysiology. 2008;1(1):2–5. DOI: 10.1161/CIRCEP.108.764233

14. Katritsis DG, Athens Euroclinic, Athens, Greece, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA, Boriani G, Cardiology Department, Modena University Hospital, University of Modena and Reggio Emilia, Modena, Italy, Cosio FG et al. Executive Summary: European Heart Rhythm Association Consensus Document on the Management of Supraventricular Arrhythmias: Endorsed by Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLAECE). Arrhythmia & Electrophysiology Review. 2016;5(3):210–24. DOI: 10.15420/aer.2016:5.3.GL1

15. Lip GYH, Heinzel FR, Gaita F, Juanatey JRG, Le Heuzey JY, Potpara T et al. European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Europace. 2016;18(1):12–36. DOI: 10.1093/europace/euv191

16. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2016;37(27):2129–200. DOI: 10.1093/eurheartj/ehw128

17. Giannitsi S, Bougiakli M, Bechlioulis A, Kotsia A, Michalis LK, Naka KK. 6-minute walking test: a useful tool in the management of heart failure patients. Thera peutic Advances in Cardiovascular Disease. 2019;13:175394471987008. DOI: 10.1177/1753944719870084

18. Brazier JE, Harper R, Jones NM, O’Cathain A, Thomas KJ, Usherwood T et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ. 1992;305(6846):160–4. DOI: 10.1136/bmj.305.6846.160

19. Shah SR, Moosa PG, Fatima M, Ochani RK, Shahnawaz W, Jangda MA et al. Atrial fibrillation and heart failure- results of the CASTLE-AF trial. Journal of Community Hospital Internal Medicine Perspectives. 2018;8(4):208–10. DOI: 10.1080/20009666.2018.1495979

20. Anselmino M, Matta M, D’Ascenzo F, Bunch TJ, Schilling RJ, Hunter RJ et al. Catheter Ablation of Atrial Fibrillation in Patients with Left Ventricular Systolic Dysfunction: A Systematic Review and Meta-Analysis. Circulation: Arrhythmia and Electrophysiology. 2014;7(6):1011–8. DOI: 10.1161/CIRCEP.114.001938

21. Ardashev A.V., Zhelyakov E.G., Duplyakov D.V., Konev A.V., Rybachenko M.S., Glukhova V.L. et al. Long-Term Results of Radiofrequency Catheter Ablation of Long-lasting Persistent Atrial Fibrillation: Five Years of Follow-up. Kardiologiia. 2013;53(6):4–11.